SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-24-013786
Filing Date
2024-03-29
Accepted
2024-03-29 16:05:04
Documents
87
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K avtx-20231231.htm   iXBRL 10-K 1940007
2 EX-3.2 ex-32fifthamendedandrestat.htm EX-3.2 140682
3 EX-23.1 ex-2312023.htm EX-23.1 16333
4 EX-31.1 ex-3112023.htm EX-31.1 10532
5 EX-31.2 ex-3122023.htm EX-31.2 10318
6 EX-32.1 ex-3212023.htm EX-32.1 11083
12 GRAPHIC avtx-20231231_g1.jpg GRAPHIC 492886
  Complete submission text file 0001628280-24-013786.txt   10047904

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avtx-20231231.xsd EX-101.SCH 68626
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avtx-20231231_cal.xml EX-101.CAL 81455
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avtx-20231231_def.xml EX-101.DEF 366019
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avtx-20231231_lab.xml EX-101.LAB 823904
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avtx-20231231_pre.xml EX-101.PRE 591672
91 EXTRACTED XBRL INSTANCE DOCUMENT avtx-20231231_htm.xml XML 919965
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37590 | Film No.: 24804123
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)